Teva Pharmaceutical Industries Ltd (TEVJF) Notes Payables (2009 - 2017)
Teva Pharmaceutical Industries' (TEVJF) quarterly Notes Payables came in at $1.0 million in Q4 2017, down 93.33% YoY from $15.0 million in Q4 2016, and down 93.33% on a QoQ basis from $15.0 million in Q4 2016.
Teva Pharmaceutical Industries Ltd (TEVJF) Notes Payables (2009 - 2017) Analysis & Trends
Teva Pharmaceutical Industries (TEVJF) has 7 years of Notes Payables data on file, last reported at $1.0 million in Q4 2017.
- Quarterly Notes Payables fell 93.33% year-over-year to $1.0 million in Q4 2017, while the trailing twelve-month figure through Dec 2017 was $1.0 million (down 93.33% YoY) and the FY2017 annual result came in at $1.0 million, down 93.33% from the prior year.
- Notes Payables retreated to $1.0 million in Q4 2017, from $15.0 million in the prior quarter.
- In the past five years, Notes Payables ranged from a high of $75.0 million in Q4 2015 to a low of $1.0 million in Q4 2017.
- A 4-year average of $32.6 million and a median of $26.0 million in 2016 frame the typical range for Notes Payables.
- Annual changes were most pronounced in 2015 — Notes Payables surged 63.04% — and 2017, when it tumbled 93.33%.
- Tracing TEVJF's Notes Payables over 4 years: stood at $46.0 million in 2014, then surged by 63.04% to $75.0 million in 2015, then tumbled by 80.0% to $15.0 million in 2016, then plunged by 93.33% to $1.0 million in 2017.
- The last three Notes Payables figures came in at $1.0 million (Q4 2017), $15.0 million (Q4 2016), and $26.0 million (Q1 2016), per Business Quant data.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | 1.00 Mn |
| Dec 31, 2016 | 15.00 Mn |
| Mar 31, 2016 | 26.00 Mn |
| Dec 31, 2015 | 75.00 Mn |
| Dec 31, 2014 | 46.00 Mn |
| Dec 31, 2011 | 2.59 Bn |
| Dec 31, 2010 | 742.00 Mn |
| Dec 31, 2009 | 95.00 Mn |